Ayala Pharmaceuticals
Ayala Pharmaceuticals
Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.
About
Technology stack
detected 2026-06-26No comments yet. Be the first to share your take.
What does Ayala Pharmaceuticals do?
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company focused on developing and commercializing novel small molecule therapeutics for patients with rare tumors and aggressive cancers. Their pipeline targets specific genetic alterations that drive tumor growth and resistance to existing therapies.
How much funding has Ayala Pharmaceuticals raised?
Ayala Pharmaceuticals has raised a total of $72M in funding. The most recent round on record is Series C.
Where is Ayala Pharmaceuticals headquartered?
Ayala Pharmaceuticals is headquartered in Jerusalem, Israel.
When was Ayala Pharmaceuticals founded?
Ayala Pharmaceuticals was founded in 2017.
What industry does Ayala Pharmaceuticals operate in?
Ayala Pharmaceuticals operates in Life Sciences, Oncology, Therapeutics, Biotech, Drug Discovery, Clinical Trials.